Radiosurgery for Brain Metastases: Challenges in Imaging Interpretation after Treatment.
brain metastasis
immunotherapy
magnetic resonance imaging
radiation necrosis
stereotactic radiosurgery
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
21 Oct 2023
21 Oct 2023
Historique:
received:
01
09
2023
revised:
13
10
2023
accepted:
18
10
2023
medline:
28
10
2023
pubmed:
28
10
2023
entrez:
28
10
2023
Statut:
epublish
Résumé
Stereotactic radiosurgery (SRS) has transformed the management of brain metastases by achieving local tumor control, reducing toxicity, and minimizing the need for whole-brain radiation therapy (WBRT). This review specifically investigates radiation-induced changes in patients treated for metastasis, highlighting the crucial role of magnetic resonance imaging (MRI) in the evaluation of treatment response, both at very early and late stages. The primary objective of the review is to evaluate the most effective imaging techniques for assessing radiation-induced changes and distinguishing them from tumor growth. The limitations of conventional imaging methods, which rely on size measurements, dimensional criteria, and contrast enhancement patterns, are critically evaluated. In addition, it has been investigated the potential of advanced imaging modalities to offer a more precise and comprehensive evaluation of treatment response. Finally, an overview of the relevant literature concerning the interpretation of brain changes in patients undergoing immunotherapies is provided.
Identifiants
pubmed: 37894459
pii: cancers15205092
doi: 10.3390/cancers15205092
pmc: PMC10605307
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
PLoS One. 2020 Nov 3;15(11):e0241835
pubmed: 33141861
Cancer Med. 2018 Oct;7(10):4870-4879
pubmed: 30133176
J Neurooncol. 2020 Jan;146(2):339-346
pubmed: 31873875
Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):1028-1038
pubmed: 31959544
Prog Neurol Surg. 2012;25:273-86
pubmed: 22236688
J Neurosurg. 2016 Jul;125(1):17-23
pubmed: 26544782
J Magn Reson Imaging. 2018 May 7;:
pubmed: 29734497
J Nucl Med. 2008 May;49(5):694-9
pubmed: 18413375
AJNR Am J Neuroradiol. 2006 Aug;27(7):1419-25
pubmed: 16908550
Lancet Oncol. 2015 Jun;16(6):e270-8
pubmed: 26065612
Radiat Oncol. 2019 Apr 15;14(1):65
pubmed: 30992043
Oncogene. 2003 Sep 1;22(37):5897-906
pubmed: 12947396
Radiology. 1999 Jun;211(3):807-14
pubmed: 10352610
J Nucl Med. 2014 Jan;55(1):30-6
pubmed: 24167081
Curr Oncol Rep. 2019 Jun 19;21(8):66
pubmed: 31218455
Neuro Oncol. 2018 Mar 27;20(4):567-575
pubmed: 29016814
Neurosurg Rev. 2014 Apr;37(2):193-201; discussion 201
pubmed: 24233257
J Neuroradiol. 2019 May;46(3):186-192
pubmed: 29752976
Clin Cancer Res. 2007 Jun 15;13(12):3449-59
pubmed: 17575207
Neurosurgery. 2007 Feb;60(2):277-83; discussion 283-4
pubmed: 17290178
AJR Am J Roentgenol. 2018 Jul;211(1):168-175
pubmed: 29708785
Radiat Oncol. 2011 May 15;6:48
pubmed: 21575163
Neuro Oncol. 2015 Mar;17(3):457-65
pubmed: 25452395
J Neurooncol. 2010 Aug;99(1):81-8
pubmed: 20058049
AJNR Am J Neuroradiol. 2018 Jun;39(6):1025-1031
pubmed: 29724761
Clin Transl Radiat Oncol. 2022 May 04;35:44-55
pubmed: 35601799
N Engl J Med. 2010 Aug 19;363(8):711-23
pubmed: 20525992
Lancet. 2004 May 22;363(9422):1665-72
pubmed: 15158627
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11
pubmed: 25182751
Ther Adv Med Oncol. 2018 Jan 18;10:1758834017742575
pubmed: 29383033
Dtsch Arztebl Int. 2021 Nov 12;(Forthcoming):
pubmed: 34730083
Neuro Oncol. 2020 Jan 11;22(1):17-30
pubmed: 31437274
Exp Ther Med. 2014 Sep;8(3):754-758
pubmed: 25120594
Hematol Oncol Stem Cell Ther. 2023 Jan 12;16(1):1-20
pubmed: 36634277
Int J Mol Sci. 2014 Jul 03;15(7):11832-46
pubmed: 24995696
J Magn Reson Imaging. 2015 Nov;42(5):1362-8
pubmed: 25865833
Expert Rev Neurother. 2016 Aug;16(8):903-14
pubmed: 27177183
Clin Cancer Res. 2004 May 15;10(10):3342-53
pubmed: 15161688
Radiol Med. 2022 Jul;127(7):773-783
pubmed: 35606609
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
J Clin Oncol. 2019 Jan 1;37(1):52-60
pubmed: 30407895
Semin Radiat Oncol. 2008 Oct;18(4):240-3
pubmed: 18725110
J Neurooncol. 2017 Jun;133(2):357-368
pubmed: 28434110
Front Oncol. 2021 Oct 26;11:711405
pubmed: 34765539
Eur J Radiol Open. 2017 Jul 10;4:84-88
pubmed: 28725661
AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5
pubmed: 26427832
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1236-1243
pubmed: 30353872
Neuro Oncol. 2015 Jan;17(1):29-44
pubmed: 25267803
Acta Neuropathol. 2006 Mar;111(3):197-212
pubmed: 16463065
Neuro Oncol. 2016 Jun;18(6):873-80
pubmed: 26688076
Surg Neurol. 2008 Jan;69(1):62-8; discussion 68
pubmed: 18054618
AJNR Am J Neuroradiol. 2009 Feb;30(2):367-72
pubmed: 19022867
Cancer Immunol Res. 2016 Mar;4(3):179-82
pubmed: 26701266
J Neurooncol. 2018 May;138(1):133-139
pubmed: 29392588
J Nucl Med. 2012 Sep;53(9):1367-74
pubmed: 22872742
AJR Am J Roentgenol. 2013 Sep;201(3):W495-510
pubmed: 23971482
Cancer Med. 2017 Apr;6(4):761-767
pubmed: 28303695
Semin Radiat Oncol. 2009 Apr;19(2):122-32
pubmed: 19249650
Int J Mol Sci. 2018 Sep 07;19(9):
pubmed: 30205431
Neuro Oncol. 2020 Jun 9;22(6):797-805
pubmed: 31956919
Front Oncol. 2018 Sep 28;8:395
pubmed: 30324090
Clin Oncol (R Coll Radiol). 2019 Jan;31(1):41-49
pubmed: 30274767
Lancet Oncol. 2018 May;19(5):672-681
pubmed: 29602646
J Oncol Pract. 2016 Aug;12(8):703-12
pubmed: 27511715
AJNR Am J Neuroradiol. 2011 Nov-Dec;32(10):1885-92
pubmed: 21920854
J Neurooncol. 2021 Dec;155(3):325-333
pubmed: 34689307
Front Neurol. 2020 Apr 15;11:270
pubmed: 32351445
BMC Med Imaging. 2014 Aug 03;14:26
pubmed: 25086595
N Engl J Med. 2018 Aug 23;379(8):722-730
pubmed: 30134131